SIGA TECHNOLOGIES INC

Explore SIGA Technologies: a Nasdaq-listed pharma innovator focused on oral antiviral therapy for smallpox, blending strong financials with global health impact.

Explore how Ghana’s State Interests and Governance Authority is reshaping state ownership, driving intra‑portfolio trading, and boosting public‑sector value.

SIGA Technologies reported mixed Q1 2025 financial results, but its strategic positioning and partnerships suggest a promising future for the pharmaceutical company.

SIGA Technologies donated $375,000 to the Equip the Vic fundraising campaign, highlighting the company’s commitment to social responsibility while navigating fluctuations in its stock price and financial valuation.

SIGA Technologies Inc. is a commercial-stage pharmaceutical company making strides in antiviral drug development, particularly in combating smallpox, with a focus on innovative oral antiviral solutions.